{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:37Z","timestamp":1792801717669,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Association Fran\u00e7aise contre les Myopathies"},{"name":"European Community"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jaut.2013.12.018","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T03:00:22Z","timestamp":1390014022000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Thymoma-associated myasthenia gravis: On the search for a pathogen signature"],"prefix":"10.1016","volume":"52","author":[{"given":"Perrine","family":"Cufi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Soussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Truffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Fetouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Robinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7522-5974","authenticated-orcid":false,"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.12.018_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000212371","article-title":"Myasthenia gravis with anti-acetylcholine receptor antibodies","volume":"26","author":"Meriggioli","year":"2009","journal-title":"Front Neurol Neurosci"},{"key":"10.1016\/j.jaut.2013.12.018_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/08916930903518073","article-title":"The auto-antigen repertoire in myasthenia gravis","volume":"43","author":"Vrolix","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2013.12.018_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2013.12.018_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2013.12.018_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","article-title":"Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study","volume":"44","author":"Filosso","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jaut.2013.12.018_bib6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1172\/JCI112069","article-title":"Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex","volume":"76","author":"Savino","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2013.12.018_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas","volume":"149","author":"Scarpino","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2013.12.018_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.12.018_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nature06066","article-title":"An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus","volume":"448","author":"Giraud","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.12.018_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.20340","article-title":"Selective loss of regulatory T cells in thymomas","volume":"56","author":"Strobel","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.018_bib11","first-page":"369","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2013.12.018_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2013.12.018_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/107999003321532475","article-title":"Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia","volume":"23","author":"Slavikova","year":"2003","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jaut.2013.12.018_bib14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1212\/WNL.50.5.1266","article-title":"Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)","volume":"50","author":"Rudick","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.12.018_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2249.1991.tb05686.x","article-title":"Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis","volume":"85","author":"Ikeda","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2013.12.018_bib16","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.ppat.0020062","article-title":"The thymus is a common target organ in infectious diseases","volume":"2","author":"Savino","year":"2006","journal-title":"PLoS Path"},{"key":"10.1016\/j.jaut.2013.12.018_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.018_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1309\/CAV8RNU5TKNACKNC","article-title":"Thymoma classification: current status and future trends","volume":"125","author":"Suster","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaut.2013.12.018_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.cdd.4401611","article-title":"Thymic myoid cells protect thymocytes from apoptosis and modulate their differentiation: implication of the ERK and Akt signaling pathways","volume":"12","author":"Le Panse","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jaut.2013.12.018_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2012.11.003","article-title":"Detection and genotyping of human papillomavirus by real-time PCR assay","volume":"56","author":"Moreau","year":"2013","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jaut.2013.12.018_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/intimm\/dxg088","article-title":"Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor","volume":"15","author":"Shiono","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaut.2013.12.018_bib22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.12.018_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2013.12.018_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ng1193-225","article-title":"Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice","volume":"5","author":"Harvey","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2013.12.018_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.12.018_bib26","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1128\/JVI.79.17.11105-11114.2005","article-title":"Down-regulation of p53 by double-stranded RNA modulates the antiviral response","volume":"79","author":"Marques","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2013.12.018_bib27","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<639::AID-IJC5>3.0.CO;2-Y","article-title":"p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma","volume":"73","author":"Hirabayashi","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaut.2013.12.018_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2006.02.012","article-title":"Elevation of IL-12 p40 and its antibody in myasthenia gravis with thymoma","volume":"175","author":"Yoshikawa","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2013.12.018_bib29","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaut.2013.12.018_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1196\/annals.1405.021","article-title":"Autoimmunizing mechanisms in thymoma and thymus","volume":"1132","author":"Willcox","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2013.12.018_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.016","article-title":"Central role of interferon-beta in thymic events leading to myasthenia gravis","volume":"52","author":"Cufi","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2013.12.018_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jmb.2004.05.059","article-title":"Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers","volume":"341","author":"Lamken","year":"2004","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jaut.2013.12.018_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2006.11.053","article-title":"Differential receptor subunit affinities of type I interferons govern differential signal activation","volume":"366","author":"Jaks","year":"2007","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jaut.2013.12.018_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/jmbi.1999.3230","article-title":"Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2","volume":"294","author":"Piehler","year":"1999","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jaut.2013.12.018_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1386-6346(02)00020-7","article-title":"Different antiviral activities of IFN-alpha subtypes in human liver cell lines: synergism between IFN-alpha2 and IFN-alpha8","volume":"24","author":"Yamamoto","year":"2002","journal-title":"Hepatol Res off J Jpn Soc Hepatol"},{"key":"10.1016\/j.jaut.2013.12.018_bib36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/jir.1996.16.1027","article-title":"Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency","volume":"16","author":"Foster","year":"1996","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jaut.2013.12.018_bib37","first-page":"57","article-title":"The role of human papillomavirus in nongenital cancers","volume":"63","author":"Zandberg","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaut.2013.12.018_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.mi.48.100194.002235","article-title":"Human papillomaviruses","volume":"48","author":"zur Hausen","year":"1994","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.jaut.2013.12.018_bib39","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions","volume":"153","author":"Sano","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2013.12.018_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1432-0436.1986.tb00385.x","article-title":"The human thymic microenvironment: thymic epithelium contains specific keratins associated with early and late stages of epidermal keratinocyte maturation","volume":"31","author":"Laster","year":"1986","journal-title":"Differentiation"},{"key":"10.1016\/j.jaut.2013.12.018_bib41","doi-asserted-by":"crossref","first-page":"785825","DOI":"10.1155\/2012\/785825","article-title":"Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment","volume":"2012","author":"DeCarlo","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jaut.2013.12.018_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.25400","article-title":"Association between toll-like receptor expression and human papillomavirus type 16 persistence","volume":"128","author":"Daud","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaut.2013.12.018_bib43","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/PAS.0b013e3182863fc1","article-title":"Human papillomavirus is not an etiologic agent of urothelial inverted papillomas","volume":"37","author":"Alexander","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaut.2013.12.018_bib44","doi-asserted-by":"crossref","first-page":"e65189","DOI":"10.1371\/journal.pone.0065189","article-title":"Overexpression of p16(INK4a) in urothelial carcinoma in Situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection","volume":"8","author":"Steinestel","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2013.12.018_bib45","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2013.12.018_bib46","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2011.03636.x","article-title":"High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis","volume":"19","author":"Csuka","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaut.2013.12.018_bib47","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/JVI.73.3.2212-2221.1999","article-title":"Measles virus infection induces terminal differentiation of human thymic epithelial cells","volume":"73","author":"Valentin","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2013.12.018_bib48","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/JVI.76.13.6415-6424.2002","article-title":"Interferons mediate terminal differentiation of human cortical thymic epithelial cells","volume":"76","author":"Vidalain","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2013.12.018_bib49","first-page":"219","article-title":"Retrovirus-like particles in human thymomas","volume":"15","author":"Arimori","year":"1990","journal-title":"Tokai J Exp Clin Med"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:08:14Z","timestamp":1760256494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":49,"alternative-id":["S0896841114000043"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.12.018","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymoma-associated myasthenia gravis: On the search for a pathogen signature","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}